GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease

NCT03823404 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

643

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: COR388 capsule
DRUG: Placebo capsule

Sponsor

Cortexyme Inc.